Antiprotozoan activity of nitroimidazoles.
D000562:Amebiasis / Q000188:drug therapy; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D056890:Eukaryota / Q000187:drug effects; D005260:Female; D005872:Giardia / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D007891:Leishmania / Q000187:drug effects; D008795:Metronidazole / Q000009:adverse effects / Q000627:therapeutic use; D051379:Mice; D011528:Protozoan Infections / Q000188:drug therapy*; D051381:Rats; D014244:Trichomonas / Q000187:drug effects; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D014345:Trypanosoma / Q000187:drug effects
D000981:Antiprotozoal Agents; D007093:Imidazoles; D008795:Metronidazole